Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...

Kira Andersen, a widowed mother, is transforming her loss into advocacy, raising over $2 million for pancreatic cancer ...

Darren Raddysh walked the halls of Moffitt Cancer Center in Tampa on Thursday, making sure to stop every few feet to interact ...

Researchers have discovered that different dietary fats may have dramatically different effects on pancreatic cancer, with ...

A new national pilot program will provide pancreatic cancer patients across Canada with free access to advanced genomic ...

The theme park says the new ride is "expected to be one of the tallest coasters in the world and (have) a record-breaking ...

Researchers found that people gaining the most weight between ages 17 and 60 faced significantly higher risks of cancers ...

The End Brain Cancer Initiative (EBCI) announced its 2026 recipient of the National HOPE Award: Becky Moroney, a ...

Israeli Ministry of Health approved the initiation of Silexion's Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancerClinical ...

Mike Birmelin's memory lives on in the form of "Bubba's Camp" a three-day youth hoops clinic that's about so much more than ...

Increase in stockholder equity and note extension strengthen Company’s ability to advance pancreatic cancer development ...